BlackRock’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-11,404,974
Closed -$68.8M 5063
2019
Q4
$68.8M Sell
11,404,974
-146,682
-1% -$884K ﹤0.01% 2157
2019
Q3
$41.6M Buy
11,551,656
+148,140
+1% +$533K ﹤0.01% 2392
2019
Q2
$30.6M Sell
11,403,516
-58,336
-0.5% -$156K ﹤0.01% 2577
2019
Q1
$33.9M Sell
11,461,852
-639,325
-5% -$1.89M ﹤0.01% 2487
2018
Q4
$19.2M Buy
12,101,177
+175,818
+1% +$280K ﹤0.01% 2732
2018
Q3
$43.9M Buy
11,925,359
+61,683
+0.5% +$227K ﹤0.01% 2431
2018
Q2
$33.6M Buy
11,863,676
+159,694
+1% +$452K ﹤0.01% 2564
2018
Q1
$43.4M Buy
11,703,982
+131,967
+1% +$490K ﹤0.01% 2343
2017
Q4
$33.3M Buy
11,572,015
+1,736,124
+18% +$5M ﹤0.01% 2491
2017
Q3
$44.2M Buy
9,835,891
+305,749
+3% +$1.37M ﹤0.01% 2339
2017
Q2
$43.7M Sell
9,530,142
-378,230
-4% -$1.74M ﹤0.01% 2324
2017
Q1
$41.7M Buy
9,908,372
+9,853,155
+17,844% +$41.5M ﹤0.01% 2320
2016
Q4
$229K Buy
55,217
+7,777
+16% +$32.3K ﹤0.01% 2011
2016
Q3
$385K Buy
47,440
+22,788
+92% +$185K ﹤0.01% 1807
2016
Q2
$192K Buy
24,652
+16,705
+210% +$130K ﹤0.01% 2090
2016
Q1
$61K Buy
7,947
+3,925
+98% +$30.1K ﹤0.01% 2210
2015
Q4
$43K Buy
4,022
+1,148
+40% +$12.3K ﹤0.01% 2118
2015
Q3
$20K Hold
2,874
﹤0.01% 2377
2015
Q2
$26K Sell
2,874
-152
-5% -$1.38K ﹤0.01% 2237
2015
Q1
$29K Buy
3,026
+263
+10% +$2.52K ﹤0.01% 2157
2014
Q4
$33K Sell
2,763
-22,327
-89% -$267K ﹤0.01% 2111
2014
Q3
$250K Buy
25,090
+22,202
+769% +$221K ﹤0.01% 1434
2014
Q2
$22K Hold
2,888
﹤0.01% 2296
2014
Q1
$9K Hold
2,888
﹤0.01% 2787
2013
Q4
$9K Hold
2,888
﹤0.01% 2772
2013
Q3
$8K Hold
2,888
﹤0.01% 2792
2013
Q2
$24K Buy
+2,888
New +$24K ﹤0.01% 2202